biotech · SCNI
Scinai Immunotherapeutics
Scinai Immunotherapeutics patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
JERUSALEM, L3, USA HQ
Public company Type
SCNI · NYSE Ticker
Company details
- Status
- Public
- HQ
- JERUSALEM, L3, USA
- Programs
- 0
- Drugs
- 0
- Patents
- 0
Scinai Immunotherapeutics patents
0 pharmaceutical patents indexed for Scinai Immunotherapeutics. 0 expire within 24 months.
Scinai Immunotherapeutics has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does Scinai Immunotherapeutics have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Scinai Immunotherapeutics patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.